Article
Mutational Landscape of Patients Referred for Elevated Hemoglobin Level.
Current oncology (Toronto, Ont.) - 30 Sept 2022
Bhai Pratibha, Chin-Yee Benjamin, Pope Victor, Cheong Ian, Matyashin Maxim, Levy Michael A, Foroutan Aidin, Stuart Alan, Hsia Cyrus C, Lin Hanxin, Sadikovic Bekim, Chin-Yee Ian
Abstract excerpt
Background: Since the identification of JAK2 V617F and exon 12 mutations as driver mutations in polycythemia vera (PV) in 2005, molecular testing of these mutations for patients with erythrocytosis has become a routine clinical practice. However, the incidence of myeloid mutations other than the common JAK2 V617F mutation in unselected patients referred for elevated hemoglobin is not well studied. This study...
Topics
Join the communities discussing this publication.